To fulfil RNADIAGON objectives, EU partners will work on the specific aims related to their individual research focus and will go for the long-term stays to US and work there on their own research under independent supervision and guidance of senior researchers from US center.
The topic for each partner was selected accordingly to its own scientific history, background, long-term focus and funding.
All scientific objectives included within the RNADIAGON structure are closely related to the topic of small non-coding RNAs as diagnostic biomarkers in cancer.
The scientific objectives of RNADIAGON are:
the standardization of processes related to the small ncRNAs detection in clinical specimens
isolation and characterization of exosomal ncRNAs, and evaluation of their potential usage in colorectal cancer
identification of small ncRNA-based non-invasive biomarkers in colorectal cancer, hepatocellular carcinoma, and renal cell carcinoma
establishing an inter-sectoral collaborative platform between academic and industrial partners to enable long-term and sustainable translational and technological research in the field of innovative cancer diagnostics
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 824036.
Disclaimer: This website and included materials reflect only the author’s view and the Research Executive Agency is not responsible for any use that may be made of the information it contains.